[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:malignant-histiocytosis":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":15,"states":16},"Malignant Histiocytosis",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06712810","Q702 for the Treatment of Patients With Hematologic Malignancies",[11],"Phase 1","RECRUITING","2026-08-26T02:16:20.336282Z","2026-05-05T02:43:29.581486Z",[],[]]